Heme Interactions as Regulators of the Alternative Pathway Complement Responses and Implications for Heme-Associated...

Area of Science:

• Biochemistry
• Immunology
• Hematology

Background:

• Heme is essential but toxic when dysregulated, impacting cellular processes and causing oxidative stress.
• Extracellular heme interacts with plasma proteins and complement components, potentially disrupting immune pathways.
• Heme metabolism errors are linked to severe hematological disorders.

Purpose of the Study:

• To computationally evaluate heme-binding motifs (HBMs) in alternative pathway complement components (APCCs).
• To understand how heme interacts with APCCs and if genetic variations influence these interactions.
• To explore the role of heme-APCC interactions in hemostasis-driven pathologies.

Main Methods:

• Computational analysis of HBMs in 16 APCCs.
• Database mining for genetic variations (SNPs) and epigenetic modifications (PTMs) in HBMs.
• Review of heme's interactions with complement components (C1q, C3, factor I) and APCCs.

Main Results:

• Putative HBMs were identified in all 16 examined APCCs.
• Ten APCCs showed disease-associated genetic or epigenetic variations within their HBMs.
• Heme interactions with APCCs can disrupt cellular protective coats and induce hemostatic responses.

Conclusions:

• Heme's interaction with APCCs is a potential molecular mechanism in various conditions involving cell damage and vascular injury.
• Genetic variations in HBMs of APCCs may predispose individuals to specific heme-mediated pathologies.
• Dysregulated alternative pathway complement activity, driven by heme, could underlie certain hematological disorders.